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Abstract
Patient. This report describes a patient with a primary long bone adamantinoma. The lesion was initially wrongly
diagnosed as ® brous dysplasia and the patient was treated by curettage. At second local recurrence, the tumour had
progressed from an osteo® brous dysplasia-like to a full-blown classic adamantinoma, with metastatic potential to the lungs
19 years after the initial treatment. Lung metastasectomy by sternotomy was carried out twice in a period of over 3Ã years.
The patient is currently alive without evidence of other metastatic disease.
Discussion. From the ® les of the Netherlands Committee on Bone Tumors, another ® ve patients with lung metastases
were studied. All types of adamantinoma should be treated by complete en bloc resection. For patients with metastatic
spread to the lungs, close radiological follow-up and excision of tumour nodules seems to be the only logic treatment
modality.
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Introduction
Adamantinoma of the long bones was ® rst described
by Fischer in 1913.
1 It was given its name because
of the histological resemblance to the adamanti-
noma of the jaw (nowadays called ameloblastoma),
but is regarded as a distinct clinicopathological
entity.
Adamantinomas are rare skeletal neoplasms
which account for about 0.3± 0.5% of all malignant
bone tumours. About 300 cases were reported up to
1994.
2± 4 There is a slight predominance in males.
The peak age incidence lies between 11 and 30
years, females being slightly younger than males.
The de® nite site of predilection is the tibia, in which
over 85% of adamantinomas occur. Within this
bone, the tumour is usually found in the diaphysis,
but it may also extend to the metaphysis. Occasion-
ally, a multi-focal occurrence is present, in which
tibia and ® bula may both be affected. Rarely, a
pretibial soft tissue location has been reported.
5,6
The radiographic appearance varies from a small
to extensive multi-lobulated radiolucent lesion in an
area of bone destruction involving the anterior dia-
physis. The cortex is mostly thinned and the perios-
teum may be elevated with a lamellar or solid
periosteal reaction.
7± 9 The radiological differential
diagnosis includes ® brous dysplasia, (non-)ossifying
® broma or osteo® brous dysplasia (OFD), metastatic
carcinoma and vascular sarcoma.
Histologically, the tumour consists of epithelial-
like cells in strands or nests, embedded in a ® brous
or osteo® brous tissue. Two main subtypes of
adamantinoma are recognized: the so-called `classic’
adamantinoma with a predominance of epithelial
tumour cells, and the `OFD-like’ or `differentiated’
adamantinoma in which the osteo® brous compo-
nent dominates the lesion and inconspicuous epithe-
lial elements can only be recognized after use of
immunohistochemistry. Four basic patterns of epi-
thelial differentiationÐ and combinations of theseÐ
may be encountered in classic adamantinoma: a
basaloid pattern consisting of cell nests with peri-
pheral pallisading, resembling basal cell carcinoma;
a squamous pattern characterized by squamous cells
with keratinization, keratohyalin granules and inter-
cellular bridges, resembling squamous cell carci-
noma; a spindle cell pattern with large areas of
spindle cells, resembling ® brosarcoma; and a tubu-
lar pattern characterized by formation of channels,
occasionally ® lled with erythrocytes and lined by
cuboidal or ¯ attened cells, resembling vascular tu-
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mours. Regardless of its histological variety, the
epithelial nature of the tumour cells has been
con® rmed by immunohistochemistry and electron
microscopy.
10± 13
The recommended treatment is wide en bloc re-
section. Amputation may not be avoidable when
lesions contain a large soft tissue component or
when local recurrences occur. The recurrence rate
of patients treated just with biopsy or curettage is
considerably higher.
Of particular interest are recent indications of a
close relationship between adamantinoma and
OFD, a benign lesion with similar clinicopatho-
logical characteristics. Opposite theories propose
that adamantinoma may arise from OFD, or that
OFD may result from reactive tissue overgrowing
maturing neoplastic epithelial cells.
2,14± 17 OFD-like
adamantinomas in particular are sometimes dif® cult
to distinguish from OFD, considering their clinical
and histopathological features. This case report,
which has previously been described in part (case
13)
2 shows the rarely reported progression of a
primary OFD-like adamantinoma to a spindle cell
classic adamantinoma at local recurrence, with
eventual dissemination to the lungs.
Case history
In 1974, a 13-year-old girl was seen because of a
painful swelling of 1 month duration at the medial
aspect of the diaphysis of the right tibia. At the age
of six, she had twice sustained a fracture at this site.
Conventional radiographs revealed a well-de® ned,
multi-lobulated osteolytic lesion with intralesional
opaci® cations and sclerotic margins in the anterior
cortex. The lesion measured 8 3 3 3 2.5 cm. The
tumour was extensively curetted, leaving no macro-
scopic evidence of residual tumour; the site was then
rinsed with carbolic acid and was ® lled with cancel-
lous-bone chips. The histopathological diagnosis
was ® brous dysplasia. Two-and-a-half years later the
patient was treated in the same way for a recurrence.
The pathological diagnosis was then changed to
non-ossifying ® broma.
For a second recurrence with progressive symp-
toms, an en bloc resection was performed 5 years
later. Routine pathological evaluation of the re-
sected specimen revealed a large cyst bordered by
numerous spindle-shaped cells. At the periphery of
the tumour, strands of tumour cells in® ltrated the
cortex and the periosteum. Areas of loose ® brous
tissue resembling the lesions identi® ed in 1974 and
1977 were observed as well. Electron microscopic
examination showed that the spindle-shaped cells
contained microlumina, microvilli and mitochon-
dria. There were several desmosomes between the
spindle-shaped cells, a ® nding clearly characteristic
of epithelial cells. On the outer site, the cell nests
were bordered by basal lamina. Thus, the resection
specimen contained an adamantinoma of the spin-
dle cell subtype. Review of the original slides as well
as immunohistochemical analysis of the primary
tumour showed isolated and small aggregates of
keratin-positive epithelial cells.
In 1993, more than 10Ã years after the last resec-
tion, two lung metastases were detected. There were
no signs of other systemic spread and the two le-
sions were excised by sternotomy. The diagnosis of
metastases of the adamantinoma, of the same spin-
dle cell subtype, was con® rmed by histology and
immunohistochemistry. After 3Ã years, a new lung
lesion was resected. The patient is now 22 years
after diagnosis of the primary tumour.
Discussion
The rate of distant metastases in long bone
adamantinoma is about 15± 20%.
4,8 This percentage
may be higher because the indolent course of the
adamantinoma necessitates long-term follow-up,
and in the past, some patients dying from metasta-
sizing adamantinoma may not have been diagnosed
adequately. In their review in 1986, Moon and Mori
found 14 metastases in 109 cases.
4 Distant metas-
tases were mainly found in patients with a history of
local recurrence, mostly due to inadequate initial
treatment. Lungs are most frequently affected. Less
frequently, metastases are found in regional lymph
nodes, liver and bones. Pulmonary metastases ap-
pear as solid tumours of varying size and number in
the lung parenchyma and the pleura. A very late
appearance of the lung metastases, after 10 years or
more, is not unknown.
18,19
The histology of metastases of an adamantinoma
shows the predominance of a spindle cell differen-
tiation of the epithelial component, as in our pa-
tient. The osteo® brous component, which is of
benign nature, is always absent. Because of the
resemblance of this epithelial subtype to some spin-
dle cell sarcomas like ® brosarcoma, the epithelial
nature of the tumour cells can often only be
con® rmed after immunohistochemistry for keratins
(the cytoskeletal proteins present in epithelial cells).
From the ® les of the registry of the Netherlands
Committee on Bone Tumors containing approxi-
mately 10 500 patients registered between 1953 and
1996, 37 patients (0,35%) with an adamantinoma
of long bone have been reported.
2,20,21 All of these
cases were reviewed and the histopathological diag-
nosis was con® rmed. In a follow-up study of 28 of
these patients
2 with a mean duration of 10 years and
2 months, eight of these patients (29%) developed
metastases, of which six were in the lungs. All of
these patients had developed a local recurrence
before the appearance of the lung metastases and
four patients had regional or other distant metas-
tases at the time of these lung metastases. Four of
the six patients with lung metastases were treated by
metastasectomy. Apart from our current patient, all
eight patients with metastases have died of disease.Disseminating adamantinoma 111
Their mean survival after diagnosis of the ® rst meta-
stasis was 4 years and 3 months; after diagnosis of
the primary tumour, they survived 12 years and 8
months. The four deceased patients who underwent
a lung metastasectomy had a mean survival of 4
years after metastasectomy. Our patient is alive 4
years after ® rst metastasectomy without current evi-
dence of metastases. However, in contrast to three
of the four patients who died of metastatic disease,
the lungs are the only location of detected dissemi-
nation in our patient until now.
Metastasectomy is the ® rst-line treatment for
pulmonary recurrences. In the Dutch series, radio-
therapy and chemotherapy neither reduced the tu-
mour volume nor improved survival.
2 To our
knowledge, only one patient had at least stable
disease for 4Ã years after treatment with several
courses of various chemotherapeutical regimes and
® nally by radiotherapy (30 Gy/15 fractions).
22 With
some selection based on prognostic factors such as
disease-free interval, number of metastases and
radical resection, a 5-year survival after metasta-
sectomy of 36% is reported for a group of 5206
patients with a variety of malignant tumours and a
10-year survival of 26%.
23 Prognosis of metastases
of an adamantinoma is probably better but data
available in the literature are scarce. A rough ap-
proximation of the 5-year survival rate of dissemi-
nated adamantinoma appears to be in the range of
50± 60%.
2,4,8
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